Aviva Holdings’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $137M | Hold |
|
|||||
|
2023
Q2 | $113M | Hold |
|
|||||
|
2023
Q1 | $117M | Hold |
|
|||||
|
2022
Q4 | $142M | Hold |
|
|||||
|
2022
Q3 | $219M | Hold |
|
|||||
|
2022
Q2 | $211M | Hold |
|
|||||
|
2022
Q1 | $258M | Hold |
|
|||||
|
2021
Q4 | $460M | Hold |
|
|||||
|
2021
Q3 | $555M | Hold |
|
|||||
|
2021
Q2 | $507M | Hold |
|
|||||
|
2021
Q1 | $537M | Hold |
|
|||||
|
2020
Q4 | $689M | Hold |
|
|||||
|
2020
Q3 | $521M | Hold |
|
|||||
|
2020
Q2 | $358M | Hold |
|
|||||
|
2020
Q1 | $241M | Buy |
|
|||||
|
2019
Q4 | $369M | Sell |
|
|||||
|
2019
Q3 | $244M | Hold |
|
|||||
|
2019
Q2 | $323M | Hold |
|
|||||
|
2019
Q1 | $230M | Hold |
|
|||||
|
2018
Q4 | $133M | Hold |
|
|||||
|
2018
Q3 | $148M | Hold |
|
|||||
|
2018
Q2 | $155M | Hold |
|
|||||
|
2018
Q1 | $96.3M | Hold |
|
|||||
|
2017
Q4 | $57.2M | Buy |
|
|||||
|
2017
Q3 | $33.7M | Sell |
|
|||||
|
2017
Q2 | $10.5M | Hold |
|
|||||
|
2017
Q1 | $15M | Buy |
|
|||||
|
2016
Q4 | $9.46M | Hold |
|
|||||
|
2016
Q3 | $13.2M | Hold |
|
|||||
|
2016
Q2 | $10.9M | Buy |
|
|||||
|
2016
Q1 | $33.3M | Buy |
|
|||||
|
2015
Q4 | $16.5M | Buy |
|